Pharma

Your Article Summary

See Latest Articles

Important New Treatment Option Approved in US for Patients with the Most Aggressive Form of Brain Cancer
Roche, 05/07/09

FDA Grants Accelerated Approval of Avastin for Brain Cancer that has progressed following prior therapy. Roche announced that the US Food and Drug Administration granted accelerated approval of Avastin for people with glioblastoma with progressive disease following prior therapy. The new indication for Avastin was granted under the FDA's accelerated approval program that allows provisional approval of medicines for cancer or other life-threatening diseases. It follows the unanimous vote by the FDA Oncologic Drugs Advisory Committee on March.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09

Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09

Mylan Receives Approval for Generic Version of Antiepileptic Keppra 1000 mg
Mylan, 12/15/09

 See all of Drug/Product Approvals